Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Pseudotumor Cerebri Market by Type (Fundoscopy, Neuroimaging, Lumbar Puncture), By Application (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Pseudotumor Cerebri Market by Type (Fundoscopy, Neuroimaging, Lumbar Puncture), By Application (Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 284081 4200 Medical Care 377 172 Pages 4.6 (49)
                                          

Market Overview:


The global pseudotumor cerebri market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of obesity, rising prevalence of chronic diseases, and growing awareness about pseudotumor cerebri. Based on type, the global pseudotumor cerebri market is segmented into fundoscopy, neuroimaging, and lumbar puncture. The fundoscopy segment is expected to account for the largest share of the global pseudotumor cerebri market in 2018. This can be attributed to the increasing use of funduscopy for early diagnosis and treatment of pseudotumor cerebri. Based on application, the global Pseudotumor Cerebri Market is segmented into spinal fluid shunt placement surgery (SFS), optic nerve sheath fenestration (ONSF), venous sinus stenting (VSS), and medication therapy/management.


Global Pseudotumor Cerebri Industry Outlook


Product Definition:


Pseudotumor cerebri is a neurological disorder that is marked by an increase in the pressure of the fluid that surrounds the brain. This condition can cause a wide range of symptoms, including headaches, vision problems, and dizziness. Pseudotumor cerebri is most often seen in women who are obese or who take certain medications, such as birth control pills or high blood pressure medications. The importance of pseudotumor cerebri lies in its ability to cause serious vision problems if left untreated.


Fundoscopy:


Fundoscopy is a diagnostic procedure for visualizing the interior of the brain. It is performed by using an optical device called a fundus camera. The normal process of looking at the retina and then processing information to form images & videos what we see on our retinas are known as fundoscopy and vitreoscopy respectively.


Neuroimaging:


Neuroimaging is a procedure that involves the use of various imaging techniques to observe and analyze the functioning of the brain. The procedures include magnetic resonance imaging (MRI), computed tomography (CT) scanning, single-photon emission computerized axial tomography (SPECT), functional Magnetic Resonance Imaging (fMRI) and Transcranial Electrical Motor Evoked Potentials(TCeMEP).


Application Insights:


Based on application, the global market is segmented into spinal fluid shunt, optic nerve sheath fenestration, venous sinus stenting, medication and others. The spinal fluid shunt held the largest share in 2017 owing to its high usage rate and preference among healthcare professionals for CSF management. However, with growing awareness regarding adverse effects of this procedure such as hydrocephalus or increased ICP there has been a decline in its usage rate over the past few years. Optic nerve sheath fenestration is expected to be one of the fastest-growing segments during forecast period due to increasing prevalence of eye disorders along with technological advancements in surgical procedures that are used for their treatment such as optic neurosurgery or transconjunctival surgery.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to increasing fundoscopic procedures, technological advancements, and high prevalence of glaucoma among the U.S.-based population. The Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to an increase in geriatric population and number of surgeries performed for various reasons such as spinal fluid shunt procedures or venous sinus stenting/fistulotomy (for drainage purposes). Moreover, rising awareness about brain tumor diagnosis using noninvasive techniques is anticipated to drive regional growth over the forecast period.


Major players operating in this industry are Carl Zeiss Meditec Group; Nikon Corporation; Ophtecs Corporation; Optomed Oy (Optic Systems); Optitech Eyecare Ltd.; PerkinElmer Inc.; SurgVision International Pty Ltd.; US WorldMate Inc.; Visionsense Pty Ltd.


Growth Factors:


  • Increasing incidence of Pseudotumor Cerebri
  • Rising awareness about Pseudotumor Cerebri and its symptoms
  • Growing number of research and development activities for the treatment of Pseudotumor Cerebri
  • Technological advancements in the diagnosis and treatment of Pseudotumor Cerebri
  • increasing healthcare expenditure

Scope Of The Report

Report Attributes

Report Details

Report Title

Pseudotumor Cerebri Market Research Report

By Type

Fundoscopy, Neuroimaging, Lumbar Puncture

By Application

Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication

By Companies

Avkare, Inc., B. Braun Melsungen AG, Beckersmith Medical, Inc., Elekta AB, Heritage Pharmaceuticals Inc., Ingenus Pharmaceuticals, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lannett Company, Inc., Magstim, Medtronic, MercuryPharma, Nostrum Laboratories Inc., Novast Holdings Ltd., Phoenix Biomedical Corp., Sanofi, SGPharma Pvt. Ltd., Sophysa, Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., West-Ward Pharmaceutical, Zydus Pharmaceuticals, Inc.

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

172

Number of Tables & Figures

121

Customization Available

Yes, the report can be customized as per your need.


Global Pseudotumor Cerebri Market Report Segments:

The global Pseudotumor Cerebri market is segmented on the basis of:

Types

Fundoscopy, Neuroimaging, Lumbar Puncture

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Spinal Fluid Shunt, Optic Nerve Sheath Fenestration, Venous Sinus Stenting, Medication

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Avkare, Inc.
  2. B. Braun Melsungen AG
  3. Beckersmith Medical, Inc.
  4. Elekta AB
  5. Heritage Pharmaceuticals Inc.
  6. Ingenus Pharmaceuticals
  7. Integra LifeSciences Corporation
  8. Johnson & Johnson Services, Inc.
  9. Lannett Company, Inc.
  10. Magstim
  11. Medtronic
  12. MercuryPharma
  13. Nostrum Laboratories Inc.
  14. Novast Holdings Ltd.
  15. Phoenix Biomedical Corp.
  16. Sanofi, SGPharma Pvt. Ltd.
  17. Sophysa
  18. Taro Pharmaceutical Industries Ltd.
  19. Teva Pharmaceutical Industries Ltd.
  20. West-Ward Pharmaceutical
  21. Zydus Pharmaceuticals, Inc.

Global Pseudotumor Cerebri Market Overview


Highlights of The Pseudotumor Cerebri Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Fundoscopy
    2. Neuroimaging
    3. Lumbar Puncture
  1. By Application:

    1. Spinal Fluid Shunt
    2. Optic Nerve Sheath Fenestration
    3. Venous Sinus Stenting
    4. Medication
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Pseudotumor Cerebri Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Pseudotumor Cerebri Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Pseudotumor cerebri is a condition in which there is an increase in the size of the brain. This can be caused by a number of things, including head trauma, infection, and tumors.

Some of the key players operating in the pseudotumor cerebri market are Avkare, Inc., B. Braun Melsungen AG, Beckersmith Medical, Inc., Elekta AB, Heritage Pharmaceuticals Inc., Ingenus Pharmaceuticals, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lannett Company, Inc., Magstim, Medtronic, MercuryPharma, Nostrum Laboratories Inc., Novast Holdings Ltd., Phoenix Biomedical Corp., Sanofi, SGPharma Pvt. Ltd., Sophysa, Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., West-Ward Pharmaceutical, Zydus Pharmaceuticals, Inc..

The pseudotumor cerebri market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pseudotumor Cerebri Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Pseudotumor Cerebri Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Pseudotumor Cerebri Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Pseudotumor Cerebri Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Pseudotumor Cerebri Market Size & Forecast, 2018-2028       4.5.1 Pseudotumor Cerebri Market Size and Y-o-Y Growth       4.5.2 Pseudotumor Cerebri Market Absolute $ Opportunity

Chapter 5 Global Pseudotumor Cerebri Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Pseudotumor Cerebri Market Size Forecast by Type
      5.2.1 Fundoscopy
      5.2.2 Neuroimaging
      5.2.3 Lumbar Puncture
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Pseudotumor Cerebri Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Pseudotumor Cerebri Market Size Forecast by Applications
      6.2.1 Spinal Fluid Shunt
      6.2.2 Optic Nerve Sheath Fenestration
      6.2.3 Venous Sinus Stenting
      6.2.4 Medication
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Pseudotumor Cerebri Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Pseudotumor Cerebri Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Pseudotumor Cerebri Analysis and Forecast
   9.1 Introduction
   9.2 North America Pseudotumor Cerebri Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Pseudotumor Cerebri Market Size Forecast by Type
      9.6.1 Fundoscopy
      9.6.2 Neuroimaging
      9.6.3 Lumbar Puncture
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Pseudotumor Cerebri Market Size Forecast by Applications
      9.10.1 Spinal Fluid Shunt
      9.10.2 Optic Nerve Sheath Fenestration
      9.10.3 Venous Sinus Stenting
      9.10.4 Medication
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Pseudotumor Cerebri Analysis and Forecast
   10.1 Introduction
   10.2 Europe Pseudotumor Cerebri Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Pseudotumor Cerebri Market Size Forecast by Type
      10.6.1 Fundoscopy
      10.6.2 Neuroimaging
      10.6.3 Lumbar Puncture
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Pseudotumor Cerebri Market Size Forecast by Applications
      10.10.1 Spinal Fluid Shunt
      10.10.2 Optic Nerve Sheath Fenestration
      10.10.3 Venous Sinus Stenting
      10.10.4 Medication
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Pseudotumor Cerebri Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Pseudotumor Cerebri Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Pseudotumor Cerebri Market Size Forecast by Type
      11.6.1 Fundoscopy
      11.6.2 Neuroimaging
      11.6.3 Lumbar Puncture
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Pseudotumor Cerebri Market Size Forecast by Applications
      11.10.1 Spinal Fluid Shunt
      11.10.2 Optic Nerve Sheath Fenestration
      11.10.3 Venous Sinus Stenting
      11.10.4 Medication
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Pseudotumor Cerebri Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Pseudotumor Cerebri Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Pseudotumor Cerebri Market Size Forecast by Type
      12.6.1 Fundoscopy
      12.6.2 Neuroimaging
      12.6.3 Lumbar Puncture
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Pseudotumor Cerebri Market Size Forecast by Applications
      12.10.1 Spinal Fluid Shunt
      12.10.2 Optic Nerve Sheath Fenestration
      12.10.3 Venous Sinus Stenting
      12.10.4 Medication
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Pseudotumor Cerebri Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Pseudotumor Cerebri Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Pseudotumor Cerebri Market Size Forecast by Type
      13.6.1 Fundoscopy
      13.6.2 Neuroimaging
      13.6.3 Lumbar Puncture
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Pseudotumor Cerebri Market Size Forecast by Applications
      13.10.1 Spinal Fluid Shunt
      13.10.2 Optic Nerve Sheath Fenestration
      13.10.3 Venous Sinus Stenting
      13.10.4 Medication
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Pseudotumor Cerebri Market: Competitive Dashboard
   14.2 Global Pseudotumor Cerebri Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Avkare, Inc.
      14.3.2 B. Braun Melsungen AG
      14.3.3 Beckersmith Medical, Inc.
      14.3.4 Elekta AB
      14.3.5 Heritage Pharmaceuticals Inc.
      14.3.6 Ingenus Pharmaceuticals
      14.3.7 Integra LifeSciences Corporation
      14.3.8 Johnson & Johnson Services, Inc.
      14.3.9 Lannett Company, Inc.
      14.3.10 Magstim
      14.3.11 Medtronic
      14.3.12 MercuryPharma
      14.3.13 Nostrum Laboratories Inc.
      14.3.14 Novast Holdings Ltd.
      14.3.15 Phoenix Biomedical Corp.
      14.3.16 Sanofi, SGPharma Pvt. Ltd.
      14.3.17 Sophysa
      14.3.18 Taro Pharmaceutical Industries Ltd.
      14.3.19 Teva Pharmaceutical Industries Ltd.
      14.3.20 West-Ward Pharmaceutical
      14.3.21 Zydus Pharmaceuticals, Inc.

Our Trusted Clients

Contact Us